BORCS7

BORCS7 is a subunit of the BLOC-one-related complex (BORC) that controls the spatial positioning of lysosomes within the cytoplasm (PMID:27158905). BORC tethers lysosomes to the kinesin microtubule motor to drive their centrifugal (anterograde) transport, and BORCS7 is essential for this tethering function (PMID:30185380). In mice, a truncating mutation in Borcs7 impairs anterograde lysosome transport in neurons and produces progressive axonal dystrophy with severe motor impairment, while complete deletion of the coding sequence is neonatal lethal, establishing BORCS7 as a central factor in axonal lysosome transport (PMID:30067980). Beyond lysosome positioning, BORCS7 is genetically and functionally linked to psychiatric and disease contexts: schizophrenia risk alleles at the 10q24.32 locus are associated with selectively increased BORCS7 brain expression (PMID:27158905), and overexpression of Borcs7 in the mouse medial prefrontal cortex produces schizophrenia-like behaviors including abnormal prepulse inhibition and social dysfunction (PMID:38718554). Direct biochemical reconstitution of the BORC complex with isolated BORCS7 has not been characterized in the available corpus.

1. 2016 Medium

   Established BORCS7 as a BORC subunit governing intracellular lysosome distribution and connected it to human disease genetics, addressing whether the gene has a defined cellular role and brain relevance.

   Evidence GWAS risk-SNP expression analysis, immunohistochemistry in human brain, and stem-cell neuronal differentiation assays

   PMID:27158905

   Open questions at the time

   • Complex membership inferred from prior BORC literature rather than direct biochemical reconstitution here
   • No mechanistic link between increased expression and behavioral or cellular phenotype
   • Causal direction of the schizophrenia eQTL association not established
2. 2018 High

   Demonstrated that BORCS7 is required in vivo for anterograde axonal lysosome transport and that its loss causes axonopathy and motor disease, answering whether the lysosome-positioning role has organismal consequences.

   Evidence Whole-genome sequencing of a spontaneous mutant, genetic complementation, knockout mouse generation, live-cell lysosome transport imaging in neurons, and behavioral motor assays

   PMID:30067980

   Open questions at the time

   • Does not resolve the molecular interface by which BORCS7 couples lysosomes to kinesin
   • Mechanism linking impaired transport to axonal dystrophy not detailed
   • Cause of neonatal lethality in full knockouts not defined
3. 2018 Medium

   Consolidated the model that BORC, via BORCS7, tethers lysosomes to kinesin for centrifugal positioning, framing the mechanistic interpretation of the mutant phenotype.

   Evidence Commentary synthesizing the primary Cell Reports lysosome-transport and motor-behavior data

   PMID:30185380

   Open questions at the time

   • Does not provide new experimental evidence
   • Identity of the kinesin and adaptor interactions for BORCS7 not directly tested
4. 2020 Medium

   Tested and excluded BORCS7 as the causal gene at the 10q24.32 blood pressure locus, clarifying which colocalized trait the gene does not drive.

   Evidence Morpholino splice-modification knockdown in zebrafish larvae with blood flow and arterial pulse measurements

   PMID:32984406

   Open questions at the time

   • Negative result limited to blood pressure parameters in larval zebrafish
   • Does not address neuronal or lysosomal phenotypes in this model
5. 2020 Low

   Implicated BORCS7 in a host pathway exploited during viral infection, raising a non-neuronal functional context.

   Evidence TMT-based comparative proteomics of HCMV-infected versus UL138-deletion mutant cells with knockdown validation of infection efficiency

   PMID:32481657

   Open questions at the time

   • Single lab screen with partial knockdown validation; no mechanistic pathway placement for BORCS7
   • Connection to lysosomal trafficking role not established
6. 2024 Medium

   Showed that elevated BORCS7 dosage in prefrontal cortex is sufficient to produce schizophrenia-like behavior, linking the disease-associated expression increase to a causal circuit phenotype.

   Evidence Borcs7 overexpression in mouse mPFC with prepulse inhibition and social interaction phenotyping, supported by CRISPR deletion, luciferase reporter, and RT-qPCR

   PMID:38718554

   Open questions at the time

   • Single study, single lab
   • Cellular mechanism linking BORCS7 overexpression to circuit dysfunction not defined
   • Relationship between behavioral effect and lysosome transport unknown

• How BORCS7 molecularly couples lysosomes to kinesin and how its dosage perturbs prefrontal circuits remains unresolved.
• No biochemical reconstitution of BORCS7 in the BORC complex
• Direct physical partners of BORCS7 not individually mapped
• Mechanistic bridge between lysosome transport and schizophrenia-like behavior absent